Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How to Optimize Your Medical Device Launch in Riverside County

May 05, 2026

Understanding the Market

Launching a medical device in Riverside County requires a deep understanding of the local market dynamics. With its proximity to major research institutions and hospitals, Riverside County offers a fertile ground for medical innovation. However, this also means the competition can be fierce. Conduct a comprehensive market analysis to identify your target audience, competitors, and potential collaborators.

medical market research

Engage with local healthcare professionals and organizations to gain insights into their needs and preferences. Understanding the specific challenges and requirements within the county can give your product a competitive edge.

Regulatory Compliance

Ensuring compliance with federal and state regulations is critical for a successful medical device launch. The U.S. Food and Drug Administration (FDA) has stringent requirements for medical devices. Familiarize yourself with these guidelines to avoid costly delays. Additionally, be aware of any state-specific regulations that may apply in California.

Consider consulting with regulatory experts or legal advisors who specialize in medical devices. Their expertise can help you navigate the complex approval process efficiently.

Developing a Marketing Strategy

Once you understand the market and regulatory landscape, focus on creating a robust marketing strategy. Start by defining your unique selling proposition (USP) and how it addresses the needs of healthcare providers and patients in Riverside County.

marketing strategy

Utilize a mix of traditional and digital marketing channels to reach your audience. This could include attending local medical conferences, leveraging social media platforms, and collaborating with healthcare influencers.

Building Local Partnerships

Forming strategic partnerships with local healthcare institutions and professionals can significantly enhance your device’s visibility and credibility. Establish relationships with hospitals, clinics, and universities in the area. These partnerships can lead to valuable endorsements and case studies.

Participate in community health events and sponsor local medical initiatives. These activities can foster trust and demonstrate your commitment to improving local healthcare outcomes.

partnership handshake

Training and Support

Providing comprehensive training and support is essential to ensure the successful adoption of your medical device. Offer training sessions for healthcare professionals to demonstrate the device’s features and benefits. Consider creating educational materials, such as videos and manuals, to assist users in getting the most out of your product.

Establish a dedicated customer support team to address any questions or technical issues. Prompt and effective support can enhance customer satisfaction and loyalty.

Monitoring and Feedback

After launching your device, closely monitor its performance in the market. Collect feedback from users and stakeholders to identify areas for improvement. This feedback loop is crucial for making necessary adjustments and enhancing the device's effectiveness.

feedback

Actively engage with your audience through surveys, focus groups, and online reviews. Demonstrating responsiveness to feedback can strengthen your brand’s reputation and customer relationships.

Continuous Improvement

Innovation in the medical field is an ongoing process. Stay informed about the latest technological advancements and industry trends to keep your device relevant. Regularly update your product based on user feedback and new research findings.

Consider setting up a research and development team dedicated to exploring new features and improvements. This proactive approach can position your company as a leader in medical device innovation.